Public Health Agency of Canada / Agence de santé public du Canada
Skip first menu Skip all menus Français Contact Us Help Search Canada Site
Home Centers & Labs Publications Guidelines A-Z Index
Check the help on Web Accessibility features Child Health Adult Health Seniors Health Surveillance Health Canada
Public Health Agency of Canada

 

 

 

Canadian Tuberculosis Committee (CTC)


Canadian Tuberculosis Committee (CTC) Membership

Provincial/Territorial TB Control Program Representatives

Alberta
Dr. Richard Long (Chair)
University of Alberta

British Columbia
Dr. Kevin Elwood
Director
Division of TB Control
British Columbia Centre for Disease Control Society

Manitoba
Dr. Pamela Orr
Director
Manitoba Tuberculosis Control Program

New Brunswick
Dr. Holy Akwar
Provincial Epidemiologist for Communicable Diseases
Office of the Chief Medical Officer of Health

Newfoundland
Dr. Faith Stratton
Provincial Medical Officer of Health
Disease Control and Epidemiology
Department of Health and Community Services

Nova Scotia
Dr. Assaad Al-Azem
Provincial Epidemiologist
Office of the Chief Medical Officer of Health
Nova Scotia Health Promotion and Protection

Northwest Territories
Cheryl Case
Communicable Disease Consultant
Health Protection - Population Health
Department of Health and Social Services

Nunavut
Elaine Randell
Communicable Disease Consultant II
Health Protection Unit
Department of Health and Social Services

Ontario
Joy Marshall
TB Nurse Consultant
Ministry of Health and Long-Term Care

Prince Edward Island
Dr. Heather Morrison
Chief Health Officer
Department of Health

Québec
Dr. Paul Rivest
Médecin conseil, Tuberculose
Ministère de la Santé et des Services sociaux

Saskatchewan
Dr. Vernon Hoeppner
Director
Saskatchewan TB Control Program
Royal University Hospital

Yukon
Colleen Hemsley
Communicable Disease Officer
Yukon Communicable Disease Control

National Reference Centre for Mycobacteriology, National Microbiology Laboratory, Public Health Agency of Canada
Joyce Wolfe
Program Manager, Mycobacteriology
Canadian Science Centre for Human and Animal Health

First Nations and Inuit Health Branch, Health Canada
Raymonde Hickey
Manager
Communicable Disease Control Division

Provincial Laboratories
Dr. Frances Jamieson
Medical Microbiologist
Public Health Laboratories Branch,
Ministry of Health and Long-Term Care, Ontario

Correctional Service Canada
Samar Sarkesh
Senior Project Officer
Infectious Diseases
Health Services Branch

Citizenship and Immigration Canada
Dr. Lise Scott
Director General
Medical Services Branch

Canadian Lung Association
Leonor Alvarado
Director of International Projects
The Lung Association, National Office

Association of Medical Microbiology and Infectious Disease Canada
Dr. Wendy Wobeser
Division of Infectious Diseases
Queen's University and Kingston General Hospital

Canadian Thoracic Society
Dr. Heather Ward
Chair, Canadian Thoracic Society, TB committee

Tuberculosis Prevention and Control, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada
Dr. Edward Ellis
Manager

Ex-officio members:
Melissa Phypers (or Derek Scholten)
Senior Epidemiologist
Tuberculosis Prevention and Control
Centre for Infectious Disease Prevention and Control
Public Health Agency of Canada

 

back to top

Canadian Tuberculosis Committee (CTC)

Updated: 2006.11.30

Terms of Reference

Mandate:
To provide scientifically based advice to the Centre for Infectious Disease Prevention and Control (CIDPC) on Canadian strategies and priorities with respect to Tuberculosis Prevention and Control, Public Health Agency of Canada.

To provide a forum to address issues of common concern related to provincial/territorial tuberculosis control programs in order to enhance tuberculosis surveillance and control activities in Canada.

The Canadian Tuberculosis Committee has no decision-making authority over programs or regulatory functions, nor is it responsible for the implementation of its advice.

Specific activities include:

  1. To review the extent to which progress has been made towards eliminating tuberculosis in Canada.
  2. To review and recommend legislation, policies, guidelines and priorities (at the municipal, provincial/territorial and federal levels) to enhance tuberculosis control programs.
  3. To review regularly the surveillance requirements for tuberculosis in Canada, including all items reportable to the national level.
  4. To review the results of national surveillance activities, including trends in tuberculosis in sub‑populations and drug resistance in Canada, and to make recommendations based on these trends.
  5. To make recommendations regarding tuberculosis educational programs for health care providers and the public and other areas in order to enhance tuberculosis control activities.
  6. To respond to requests for consultation on specific items, including making recommendations concerning items referred by the Minister of Health.
  7. To address the application of new technologies.
  8. To recommend priorities for epidemiological and laboratory tuberculosis research in Canada.

Reporting Relationship:
The Canadian Tuberculosis Committee reports to the Communicable Disease Control Expert Group, an expert group within the Pan-Canadian Public Health Network, through the Director-General, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada.

Each member also reports to his/her jurisdiction/organization and is responsible for communicating decisions and information of the Committee to their jurisdiction or organization.

Membership:
Members of the Canadian Tuberculosis Committee shall include:

  1. One representative from each province/territory (the provincial/territorial "director" of tuberculosis control or their designate)
  2. The Manager, Tuberculosis Prevention and Control, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada
  3. The Senior Medical Advisor, National Microbiology Laboratory,  Public Health Agency of Canada
  4. A representative of the Canadian Public Health Laboratory Network (provincial/territorial laboratory directors)
  5. A representative from First Nations and Inuit Health Branch, Health Canada
  6. The Director General, Medical Services Branch, Citizenship and Immigration Canada
  7. A representative of the Canadian Lung Association who will also represent Stop TB Canada
  8. The National Infectious Diseases Coordinator, Correctional Service of Canada
  9. A representative of the Association of Medical Microbiology and Infectious Disease (liaison member)
  10. A representative from the Canadian Thoracic Society
  11. Senior Epidemiologist, Tuberculosis Prevention and Control, Public Health Agency of Canada (ex-officio)
  12. Other representatives from organizations with interests in the prevention and control of tuberculosis as the Chair and Director General of Centre for Infectious Disease Prevention and Control deem necessary to effectively carry out the function of the committee
In the exercise of their functions, committee members shall act as recognized experts in their field.  Members will be required to file a confidential financial disclosure report and to declare to the Chair if the committee deliberations place them in a situation of real or perceived conflict of interest (as per the Policy Guide for the Management of Advisory Committees).

Committee members are expected to protect and maintain as confidential any classified or otherwise privileged information divulged to them in the course of the committee's work.

Functioning:
Recommendations and final reports are to be developed by the committee in concert with Tuberculosis Prevention and Control, Public Health Agency of Canada staff at the appropriate working level. These reports are to be submitted by the Committee Executive Secretary for presentation to the Director General of Centre for Infectious Disease Prevention and Control.

All members will have voting privileges except for ex-officio members.  Voting will be by consensus where possible.  In circumstances where consensus is not possible, decisions will be reached by a majority vote of full members including the Chair.  In the event of a tie, the vote is lost.

There are three standing subcommittees of the Canadian Tuberculosis Committee: the Immigration Subcommittee, the Metropolitan TB Issues Subcommittee and the Surveillance Subcommittee.

The committee or the Chair may, as the need arises, create working groups to examine specific areas or to develop position papers. The Chair of a working group shall be a member of the committee.  However, non-committee members and/or external experts may be invited to participate in working groups as required.  Recommendations are to be brought back to the committee as a whole and thus, if approved, to become recommendations of the full committee.

Chair:
The Chair shall be nominated and elected by the members, and shall be a provincial/territorial member of the committee.  The term of the Chair shall be for three (3) years.

Secretariat:
Executive Secretary: Manager, Tuberculosis Prevention and Control, Public Health Agency of Canada

Administrative Secretary: Tuberculosis Prevention and Control, Public Health Agency of Canada staff.

Minutes shall be recorded by staff of Tuberculosis Prevention and Control, Public Health Agency of Canada, and circulated to members prior to the next meeting.  Approved minutes will be forwarded to the Director General of the Centre for Infectious Disease Prevention and Control.

A member may request that significant objections to a Committee decision be included in the minutes and brought to the attention of the Director General of the Centre for Infectious Disease Prevention and Control. 

Advisory Committee Statements, issues (with motions) and deliverables will be forwarded to the Communicable Disease Control Expert Group of the Pan-Canadian Public Health Network for information or approval and/or as a pathway to the Deputy Ministers of Health.

Agenda items shall be identified by any member of the committee and forwarded to the Chair no later than one month prior to the scheduled meeting date.

Frequency of Meetings:
Meetings of the full committee shall be held at least once a year. Consideration may be given by Tuberculosis Prevention and Control, Public Health Agency of Canada to fund additional meetings of the full committee and/or any meetings of subcommittees, dependent on the need.

Committee Member Expenses:
The cost of travel and related expenses for committee members shall be borne by Tuberculosis Prevention and Control, Public Health Agency of Canada, and paid in accordance with Treasury Board policies.

November 30, 2006

 

Last Updated: 2007-09-20 Top